Other Weight Loss Medications If you are deciding between medication-only or a more holistic approach, our article on GLP-1 vs Natural Weight Loss can help guide expectations
By combining advanced pharmaceutical options with a supportive, patient-centered environment, we help you transition from the preparation phase to active weight loss with complete peace of mind
You should avoid semaglutide if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN2, active pancreatitis, or certain GI conditions
In addition, despite continuous discussions about affordability, insurers are progressively expanding reimbursement coverage, increasing the accessibility of these treatments
Microdosing refers to the use of subtherapeutic or lower-than-standard doses of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), with the aim of minimizing side effects while maintaining therapeutic benefits
As the GLP-1R is not expressed on human hepatocytes, the GLP-1RA-mediated effects on fatty liver are probably indirectly mediated through GLP-1RA-induced weight loss and ensuing improvement in insulin resistance, and, potentially, anti-inflammatory effects associated with GLP-1RA treatment (29)
